Johannes von Borries

Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany.

Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million.

Home Shopping Europe GmbH operates as a mail order company, which offers home shopping on all media platforms. The product categories include fashion, cosmetics, jewelry and watches, health and vitality, electronics, as well as home and garden. These are offered via television program, online shop, and applications on mobile devices. The company was founded on November 9, 2005 and is headquartered in Ismaning, Germany.

BridgeCo, a networked entertainment pioneer, offers the world’s most comprehensive, cost-effective and highly integrated processor IC and software platforms for connecting Internet media sources, computers and consumer electronics throughout the home. BridgeCo platforms are targeted at the multi-billion dollar global market for stand-alone after-market and embedded audio applications. BridgeCo platforms are the core technologies underlying digital media players (DMPs), audio/video receivers (AVRs), musical instruments and external multi-channel sound cards.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Deutsche Energie-Agentur GmbH provides energy services focused on environmentally friendly production, conversion, and use of energy. The joint venture company is based in Berlin, Germany. The CEOs are Andreas Kuhlmann, Kristina Haverkamp. The German company was founded in 2000.

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

btov Partners AG (btov) is a venture capital firm founded in 2000 by St. Gallen University students as an online job platform BrainsToVentures, with backing from Swiss business angels. The firm is headquartered in St. Gallen, Switzerland.

Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland.

APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany.

DPE Deutsche Private Equity GmbH (DPE) is an independent private equity firm founded in 2007 by Volker Hichert and Marc Thiery. The firm is headquartered in Munich, Germany.

UnternehmerTUM GmbH engages in the provision of business creation and innovation services. It offers opportunities recognition, concept development, business set up, and start up consulting. The company was founded by Susanne Klatten in 2002 and is headquartered in Garching, Germany.

APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria.

YARA ZIM Plant Technology GmbH develops and sells magnet sensor technology that measures continuously the water supply of leaves of intact plants with precision and under field conditions. The company was founded by Ulrich Zimmermann in 2010 and is headquartered in Hennigsdorf, Germany.

Compositence GmbH develops processes for the production of components from carbon fiber. It offers equipment, software and prototype for the production of performance composite parts and performing machinery products. The firm's clients include automotive and commercial vehicle manufacturers and aviation and wind industries. The company was founded by Ingo Karb, Rainer Kehrle and Volker Witzel in 2008 and is headquartered in Leonberg, Germany.

Synapticon GmbH components and engineering services. The firm’s solutions include target-optimized hardware designs and development of special applications. The company was founded by Andrija Feher, Martin Schwarz and Nikolai Ensslen in 2010 and is headquartered in Schonaich, Germany.

Cumulocity GmbH develops software solutions into commercially deployed products. It offers data center hosting and information technology operations, proactive system monitoring, data backup and SLA based support services. The company was founded by Stefan Vaillant, Jörg Stache, Bernd Groß and Andre Eichler in 2010 and is headquartered in Dusseldorf, Germany.

ROMO Wind AG provides products that focus on improving the wind turbine rotor function. It offers wind farm optimization, and yaw and pitch correction services. The firm also provides iSpin1, a retrofit product that is used for accurate detection and subsequent one-off correction of static or average wind turbine yaw misalignments. The company was founded by Soren Mouritsen, Poul Anker Lubker and Jan Nikolaisen in 2011 and is headquartered in Zug, Switzerland.

NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland.

ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

52Masterworks GmbH operates an online platform that provides website designing services. The company was founded by Tobias Ledermann, Björn Jopen, Christian Utz, Robert Herrmann, and Andreas Unseld in 2013 and is headquartered in München, Germany.

Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany.

Part of Freepik Co. SL, EyeEm Ltd. is a British company that provides business support services. The company is based in Birmingham, UK. EyeEm was founded in 2011.

AssetMetrix GmbH engages in the provision of asset services. It offers front, middle, and back-office solutions for pension funds, insurance companies, fund-of-funds managers, and family offices. The company was founded by Emmeram von Braun in 2013 and is headquartered in Munich, Germany.

Munich Urban Colab GmbH is a German company that focuses on sustainability as one of its key topics. The joint venture company offers space to work on innovative solutions and is located in Garching, Germany. The company believes that creating long-term value is closely related to the health of the planet and people. Digitalization is also an essential element that companies must integrate into their innovation strategy to remain viable for the future. The CEO of the company is Helmut Schönenberger.

Part of Equal 1 Laboratories Ireland Ltd., Equal1 Labs is a technology company that specializes in developing desktop quantum computers with unmatched performance, affordability, and energy efficiency. The company is based in Fremont, CA, and the CEO of the company is Dirk Leipold. The company's groundbreaking quantum processors integrate an entire quantum system onto a single chip, including millions of spin qubits, measurement and control microelectronics, AI-powered real-time error correction, and high-speed input/output.

High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany.